SCHEMBL24058987

SCHEMBL24058987

CCc1ccc2cc(CN)n(CCN(C)C)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ HTR2A P28223 3/20 0.35
▸ HTR2C P28335 3/20 0.35
▸ TERT O14746 1/20 0.34
▸ CYP2A6 P11509 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HTR1D P28221 2/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ HTR1B P28222 1/20 0.33
▸ CNR2 P34972 2/20 0.32
▸ KEAP1 Q14145 1/20 0.32
▸ NFE2L2 Q16236 1/20 0.32
▸ TAAR1 Q96RJ0 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.31
▸ HDAC3 O15379 1/20 0.31
▸ HDAC4 P56524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24059255 0.78 CYP1A2 (0.39) CYP1A2ALDH1A1POLBHTR2AHTR2C
SCHEMBL21101086 0.72 CNR2 (0.39) CYP1A2ALDH1A1POLBHTR2AHTR2C
SCHEMBL16979074 0.69 CYP1A2 (0.44) CYP1A2CYP2A6TAAR1HTR7
SCHEMBL27400363 0.67 HTR2C (0.61) HTR2AHTR2CHTR1DHTR7
SCHEMBL10667519 0.64 HTR6 (0.33) CYP1A2ALDH1A1POLBHTR2AHTR2C
SCHEMBL18731902 0.63 MAP3K14 (0.44) ALDH1A1HTR2AHTR2CHTTTDP1
SCHEMBL20853272 0.63 KDM4E (0.55) CYP1A2ALDH1A1CYP2A6TSHRHTT
SCHEMBL15345356 0.62 CYP2A6 (0.64) CYP1A2HTR2AHTR2CCYP2A6TAAR1
SCHEMBL22292651 0.61 OPRM1 (0.37) CYP1A2ALDH1A1POLBHTR2A
SCHEMBL11389628 0.61 HTT (0.43) CYP1A2ALDH1A1HTR2AHTR2CTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3421464-B1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO LTD (CN) 2021-11-24 — — EP disclosed
Send feedback